ask="11.30"
ask_size="1000"
average_daily_volume="28856"
bid="3.12"
bid_size="100"
book_value="3.34"
change="+0.49"
change_from_200_day_moving_average="3.37"
change_from_50_day_moving_average="2.34"
change_from_52_week_high="-1.00"
change_From_52_week_low="6.48"
change_in_percent="+5.15%"
close="10.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.86"
ex_dividend_date="N/A"
float_shares="N/A"
high="11.00"
high_52_weeks="11.00"
last_trade_date="2/14/2017"
last_trade_price="10.00"
last_trade_size="100"
last_trade_time="3:59pm"
low="9.50"
low_52_weeks="3.52"
market_capitalization="212.80M"
moving_average_200_day="6.63"
moving_average_50_day="7.66"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.22"
open="9.51"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+50.92%"
percent_change_from_50_day_moving_average="+30.51%"
percent_change_from_52_week_high="-9.09%"
percent_change_from_52_week_low="+184.09%"
previous_close="9.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.85"
price_per_sales="38.92"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.79"
stock_exchange="NMS"
symbol="NBRV"
volume="85771"
weeks_range_52="3.52 - 11.00"
